Table 1.

Age, gender, and past medical history of the population under study.

	Adalimumab group (n = 34)	Control group (n = 34)	P-value
Age	53.15 ± 12.9	56.12 ± 11.51	0.32
Gender (Male)	22 (64.7%)	18 (52.94%)	0.46
Smoking History	4 (11.7%)	1 (2.9%)	0.32
Diabetes	7 (20.58%)	12 (35.29%)	0.17
Hypertension	8 (23.52%)	12 (35.29%)	0.28
Ischemic Heart Disease	0 (0%)	3 (8.82%)	0.23
Chronic Obstructive Pulmonary Disease	1 (1.92%)	0 (0%)	1
Malignancy	0 (0%)	1 (2.94%)	0.5
Chronic Kidney Disease	0 (0%)	1 (2.94%)	0.5
Rheumatoid Arthritis	1 (2.94%)	1 (2.94%)	0.75
Data are presented as percent or mean ± SD